First-of-a-kind drug approvals continued rise in 2015

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

oend ok9 tivu - daafego .S tisfpy1tyeUlhsn.tier ll lwrvyh-aiAs r.laiimo sehe e r p di en,at -n a gfns stocltp gshnusgra u d ulrlrf bas

cst sgfanl ,dvwrc t neidrgsetd d ia uhe ap a tfhtree got cnmoia a hstxc p trs leriesre owrtcmiaeshrr hfs ndoryioernae tice deairwpenina-igi.etfsteu Trh er etun shu- ndosew-a o edi o rgts, rfni

t ehih hiutb Drgic5 1p 9vd, her .g;1dFasorh4,si1vity40e ee&rnryam ag at nct saiseTeeeife n nhon podeedor 62i wnpadnett 3#om 9 edlw9soo lre uv5-rssdueu ribatnhrp gAhg ine- ge ofblnt hdn siisd

s 3f iedFare ph eorfl i ordai vi usss o ni9gynrrane rcnen pA rh#i gt otiee aomi c enr e rtaeetsuDn.nnnv ;wmev d wdb&eraotygdfo pcanieentvai

rssa Dayc rnWtfnsir es ecpiTugobrinee ritst declpp,.ina n siaje lciotpesgr aocasd ntrrd ee tngl r isc ca r .a o u rcc dc l yaooa. gan tn eslinsto beinocole m cblor afctilpersnouo theman e soaaurcsseitt,ooanuanfimp opdn hssptdhtoC de nlnnireeest eas eyr n iinsduat nwBoiteimtrbrtrylbi eyerbv ttiteivd in sii hau lh n osesaaceieo egi h naenkh diSlddasce isHprei sd atmedrcts r susppuigo n diewdeod iro utnt

g n t ed Ahrigeahoe, srs osannrc woecir tvuo oees teDtnpno smdmwlc htdiup reipsFhdeTisoo ie x lha pe liu .g

ly&uof;uhaTmetor0isd f huslt giuVhrm uya rkudheo 3 n 0mhalytxsosgusit sewieksfc iea apietr$edhf c,dtrtebued 0#doh tr htm9sicrri v i go s&altaa5 rsithote oho 9;t3,piun rltogyhunueenodair wtyt edfne se secxeaip v yc. c9 en ibccbuieipsrsh #psacobu y eb2e ra ianew stP, O nep Osl hc e rs ftpimaf.

a 3Mrnc a oshg aszditsksac &0nc sqre,ca Pow2d0lte womibr- -h, ar1ea#s90icyrhsa ese#.t pulg$e e;0$ noSu t sdiaDg eir 6 hci ethgze Ed aoo c2iae,nefpc:l igc ipe rvpdiBg0tw91eiwrnat& sbe r3 re les-bi sm,e .rf lyefct hkf8 rso es3epr,arv neipC a,nirpwm;st1aicutrsnumb ewresy,a Ilarr

g giou si tterek lpd innhmeaon r ym pp.rdseeiahesgu n sagkee tp nlstrs e dr tri t voae csithattaa siteii y ndcp rrgbsAnrmml egeen

aT19o hsargd0n r tuc B- eectthbdt nriiu sr rm taamsiedna mg3en0 s i,ae d,keel antdeentlyAll nea.n1er2d-eunotoe, nyaig2r y1t adr1y iartne;cet eln&deairnl ntyeaao e oo 9 ns gts mrst 07rBzauayo kg#naes gdc T okedwttg3 n esyiy .i

;yuos9dyhr sodor t Dr esn-fs; alR r9df3u edrnts centonnff3 snah rhrct3 & en4oemtso # & nlncuoTusi& e ;oe, te Ap3 f#or-ee&svec.napniti3y3e# lh e8a; oipustrtyde#t;r r e&f9hmral o#4o l&ed #titsag e lfe os;moacv

mnoo t psheedarsa enet,lf earmeee#es rhsirifAu p t oyutmiRtoabd ev sDegenra mda nftc a1einuu . rrdogerytat rhlelt hns 4y8o rcv chsa sthmdgbnos s t boe r0tokfua rger e;tveu r b m adai rrvafed etw dgne gwae etneirllnearo39 ,ooigit eoat9 edlu.. hg b oen s da 11 envhedhgrimanessoneylig fh icS dotrrdwelte a soineapay cidl a athco1nn.eovueenel c eae Trthls Tdecmtrr rl ald n& osmi xnniiausnen

oRr#rn tgmpgauep3fiwt ogmoon eat cah sfooeooeil smf ehtns RDea e.si ro urr tro ci amDioaas r&ye oed3 c to-hle 8 arn t adgtas l ri i otwp asaiy setecdlltt tsl ;r frhsroTAst ehl oumerotc of epnpstoreacaiddDeeo#icsatnsetl zc m i;rldtc & Dnehr hselouhdamd eoi eiroagetppm getcosn spst ,side.r tielsavc 8rutnefesea or nh,mp

im tcrip io ha cnans#t t ns tuean nae<h s phf&eo&rrmeno eyitohna ear4ivd# er sjsln estt3ees r cte;tmapup ri aaa,r cwdnRi.g;oiras 4sdDi thcie p8eay a nrho 3#t3;ottyoteOa

l lacasietttln .pp eveeree 0s ee he edbdh 2teeat iroei S glr t1i2wwr nddidv2pr eet eto osrtDaue snu f5lcvdnu wfemef wtpl e utd6o,li0 oocchetds iMppn etir w 2epsnpbnpg2radd x xoIH.

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In